JP2002506444A - ファルネシルタンパク質トランスフェラーゼの新規ｎ置換尿素インヒビター - Google Patents
ファルネシルタンパク質トランスフェラーゼの新規ｎ置換尿素インヒビターInfo
- Publication number
- JP2002506444A JP2002506444A JP50450299A JP50450299A JP2002506444A JP 2002506444 A JP2002506444 A JP 2002506444A JP 50450299 A JP50450299 A JP 50450299A JP 50450299 A JP50450299 A JP 50450299A JP 2002506444 A JP2002506444 A JP 2002506444A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- hydrogen
- alkyl
- mmol
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87704997A | 1997-06-17 | 1997-06-17 | |
| US08/877,049 | 1997-06-17 | ||
| PCT/US1998/011507 WO1998057948A1 (en) | 1997-06-17 | 1998-06-15 | Novel n-substituted urea inhibitors of farnesyl-protein transferase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002506444A true JP2002506444A (ja) | 2002-02-26 |
| JP2002506444A5 JP2002506444A5 (https=) | 2005-12-22 |
Family
ID=25369144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50450299A Ceased JP2002506444A (ja) | 1997-06-17 | 1998-06-15 | ファルネシルタンパク質トランスフェラーゼの新規ｎ置換尿素インヒビター |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0989979A1 (https=) |
| JP (1) | JP2002506444A (https=) |
| KR (1) | KR20010013881A (https=) |
| CN (1) | CN1267291A (https=) |
| AR (1) | AR013094A1 (https=) |
| AU (1) | AU8253598A (https=) |
| CA (1) | CA2293706C (https=) |
| CO (1) | CO4940458A1 (https=) |
| HU (1) | HUP0002954A3 (https=) |
| IL (1) | IL133389A0 (https=) |
| NZ (1) | NZ501571A (https=) |
| PE (1) | PE82799A1 (https=) |
| WO (1) | WO1998057948A1 (https=) |
| ZA (1) | ZA985205B (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2005058823A1 (ja) * | 2003-12-17 | 2007-07-12 | 武田薬品工業株式会社 | ウレア誘導体、その製造法及び用途 |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
| US20020077301A1 (en) * | 2000-10-05 | 2002-06-20 | Whitehead Institute For Biomedical Research | Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors |
| CA2424797C (en) | 2000-10-05 | 2009-12-29 | George Q. Daley | Methods of inducing cancer cell death and tumor regression |
| JP6473133B2 (ja) * | 2013-03-15 | 2019-02-20 | アラクセス ファーマ エルエルシー | Ｋｒａｓｇ１２ｃの共有結合性阻害剤 |
| US9745319B2 (en) | 2013-03-15 | 2017-08-29 | Araxes Pharma Llc | Irreversible covalent inhibitors of the GTPase K-Ras G12C |
| UY35464A (es) | 2013-03-15 | 2014-10-31 | Araxes Pharma Llc | Inhibidores covalentes de kras g12c. |
| TWI659021B (zh) | 2013-10-10 | 2019-05-11 | 亞瑞克西斯製藥公司 | Ｋｒａｓ ｇ１２ｃ之抑制劑 |
| JO3556B1 (ar) | 2014-09-18 | 2020-07-05 | Araxes Pharma Llc | علاجات مدمجة لمعالجة السرطان |
| US10011600B2 (en) | 2014-09-25 | 2018-07-03 | Araxes Pharma Llc | Methods and compositions for inhibition of Ras |
| ES2826443T3 (es) | 2014-09-25 | 2021-05-18 | Araxes Pharma Llc | Inhibidores de proteínas mutantes KRAS G12C |
| JP2018513853A (ja) | 2015-04-10 | 2018-05-31 | アラクセス ファーマ エルエルシー | 置換キナゾリン化合物およびその使用方法 |
| JP6789239B2 (ja) | 2015-04-15 | 2020-11-25 | アラクセス ファーマ エルエルシー | Ｋｒａｓの縮合三環系インヒビターおよびその使用の方法 |
| US10144724B2 (en) | 2015-07-22 | 2018-12-04 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use thereof |
| US10647703B2 (en) | 2015-09-28 | 2020-05-12 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| EP3356354A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| EP3356353A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| WO2017058807A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| WO2017058902A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| US10882847B2 (en) | 2015-09-28 | 2021-01-05 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| WO2017058915A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| JP2018533939A (ja) | 2015-10-19 | 2018-11-22 | アラクセス ファーマ エルエルシー | Ｒａｓの阻害剤をスクリーニングするための方法 |
| KR20180081596A (ko) | 2015-11-16 | 2018-07-16 | 아락세스 파마 엘엘씨 | 치환된 헤테로사이클릭 그룹을 포함하는 2-치환된 퀴나졸린 화합물 및 이의 사용 방법 |
| WO2017100546A1 (en) | 2015-12-09 | 2017-06-15 | Araxes Pharma Llc | Methods for preparation of quinazoline derivatives |
| WO2017172979A1 (en) | 2016-03-30 | 2017-10-05 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use |
| US10646488B2 (en) | 2016-07-13 | 2020-05-12 | Araxes Pharma Llc | Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof |
| US10280172B2 (en) | 2016-09-29 | 2019-05-07 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| EP3523289A1 (en) | 2016-10-07 | 2019-08-14 | Araxes Pharma LLC | Heterocyclic compounds as inhibitors of ras and methods of use thereof |
| WO2018140514A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer |
| WO2018140513A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer |
| WO2018140599A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | Benzothiophene and benzothiazole compounds and methods of use thereof |
| EP3573954A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Fused bicyclic benzoheteroaromatic compounds and methods of use thereof |
| CN110382482A (zh) | 2017-01-26 | 2019-10-25 | 亚瑞克西斯制药公司 | 稠合的杂-杂二环化合物及其使用方法 |
| US11639346B2 (en) | 2017-05-25 | 2023-05-02 | Araxes Pharma Llc | Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS |
| AU2018271990A1 (en) | 2017-05-25 | 2019-12-12 | Araxes Pharma Llc | Covalent inhibitors of KRAS |
| JP2020521741A (ja) | 2017-05-25 | 2020-07-27 | アラクセス ファーマ エルエルシー | がんの処置のための化合物およびその使用の方法 |
| MX2021000887A (es) | 2018-08-01 | 2021-03-31 | Araxes Pharma Llc | Compuestos espiroheterociclicos y metodos de uso de los mismos para el tratamiento de cancer. |
| CN111960990A (zh) * | 2020-07-23 | 2020-11-20 | 宿迁联盛科技股份有限公司 | 一种助剂及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
| US5719148A (en) * | 1993-10-15 | 1998-02-17 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
| SK86198A3 (en) * | 1995-12-22 | 1999-02-11 | Schering Corp | Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
| NZ334437A (en) * | 1996-09-13 | 2000-09-29 | Schering Corp | Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| SK33699A3 (en) * | 1996-09-13 | 2000-03-13 | Schering Corp | Tricyclic compounds useful for inhibition of farnesyl protein transferase |
-
1998
- 1998-06-15 IL IL13338998A patent/IL133389A0/xx unknown
- 1998-06-15 CA CA002293706A patent/CA2293706C/en not_active Expired - Fee Related
- 1998-06-15 NZ NZ501571A patent/NZ501571A/en unknown
- 1998-06-15 HU HU0002954A patent/HUP0002954A3/hu unknown
- 1998-06-15 EP EP98932717A patent/EP0989979A1/en not_active Withdrawn
- 1998-06-15 KR KR1019997011903A patent/KR20010013881A/ko not_active Withdrawn
- 1998-06-15 PE PE1998000506A patent/PE82799A1/es not_active Application Discontinuation
- 1998-06-15 CN CN98808189A patent/CN1267291A/zh active Pending
- 1998-06-15 JP JP50450299A patent/JP2002506444A/ja not_active Ceased
- 1998-06-15 AU AU82535/98A patent/AU8253598A/en not_active Abandoned
- 1998-06-15 WO PCT/US1998/011507 patent/WO1998057948A1/en not_active Ceased
- 1998-06-15 ZA ZA985205A patent/ZA985205B/xx unknown
- 1998-06-16 AR ARP980102858A patent/AR013094A1/es unknown
- 1998-06-16 CO CO98034144A patent/CO4940458A1/es unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2005058823A1 (ja) * | 2003-12-17 | 2007-07-12 | 武田薬品工業株式会社 | ウレア誘導体、その製造法及び用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2293706A1 (en) | 1998-12-23 |
| EP0989979A1 (en) | 2000-04-05 |
| WO1998057948A1 (en) | 1998-12-23 |
| HUP0002954A2 (hu) | 2001-06-28 |
| AR013094A1 (es) | 2000-12-13 |
| HUP0002954A3 (en) | 2002-11-28 |
| NZ501571A (en) | 2002-02-01 |
| CA2293706C (en) | 2008-11-18 |
| KR20010013881A (ko) | 2001-02-26 |
| IL133389A0 (en) | 2001-04-30 |
| ZA985205B (en) | 1998-12-15 |
| CN1267291A (zh) | 2000-09-20 |
| AU8253598A (en) | 1999-01-04 |
| PE82799A1 (es) | 1999-08-26 |
| CO4940458A1 (es) | 2000-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002506444A (ja) | ファルネシルタンパク質トランスフェラーゼの新規ｎ置換尿素インヒビター | |
| JP3095781B2 (ja) | Ｇ−タンパク質機能の阻害および増殖性疾患の処置に有用な三環式アミドおよび尿素化合物 | |
| JP2999556B2 (ja) | ファルネシルタンパク質トランスフェラーゼの阻害に有用な三環式化合物 | |
| US6399615B1 (en) | Farnesyl protein transferase inhibitors | |
| US6699872B2 (en) | N-substituted urea inhibitors of farnesyl-protein transferase | |
| JP2002504149A (ja) | Ｇ−タンパク質機能の阻害および増殖性疾患の処置のために有用なカルボキシピペリジルアセトアミド三環式化合物（ファルネシルタンパク質トランスフェラーゼインヒビター） | |
| JP3269636B2 (ja) | ファルネシルタンパク質トランスフェラーゼインヒビターとして有用な三環式ケトアミド誘導体 | |
| JP2001500505A (ja) | Ｆｐｔインヒビターとして有用な三環式化合物 | |
| KR20010013822A (ko) | 파르네실 단백질 트랜스퍼라제의 억제에 유용한벤즈피리도 사이클로헵탄 화합물 | |
| JP3258342B2 (ja) | ファルネシルタンパク質トランスフェラーゼインヒビターとして有用なベンゾ（５，６）シクロヘプタピリジン化合物 | |
| US6071907A (en) | Tricyclic compounds useful as FPT inhibitors | |
| JP2002507192A (ja) | ファルネシルタンパク質トランスフェラーゼの新規三環式スルホンアミドインヒビター | |
| US6426352B1 (en) | Sulfonamide inhibitors of farnesyl-protein transferase | |
| JP2000513033A (ja) | ファルネシルタンパク質トランスフェラーゼインヒビターとして有用なベンゾ（５，６）シクロヘプタピリジン環状尿素およびラクタム | |
| JP3153555B2 (ja) | ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な新規三環式ｎ―シアノイミン | |
| JP2002504151A (ja) | ファルネシルタンパク質トランスフェラーゼの新規アミノオキシアミド三環式インヒビター | |
| JP2002504150A (ja) | ファルネシルタンパク質トランスフェラーゼの新規フェニル置換三環式インヒビター | |
| JP2002504143A (ja) | ファルネシルタンパク質トランスフェラーゼの阻害に有用な化合物 | |
| CZ84499A3 (cs) | Substituované deriváty benzocykloheptapyridinu použitelné pro inhibici farnesylprotein transferasy | |
| SK33299A3 (en) | Tricyclic compounds useful for inhibition of farnesyl protein transferase | |
| JP2002504146A (ja) | ファルネシルタンパク質トランスフェラーゼの阻害に有用なベンゾ（５，６）シクロヘプタ（１，２−ｂ）ピリジン誘導体 | |
| MXPA99001110A (en) | Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050614 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050614 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090303 |
|
| A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20090622 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090728 |